Augé C - Search Results

1

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.

Oberst MD, Augé C, Morris C, Kentner S, Mulgrew K, McGlinchey K, Hair J, Hanabuchi S, Du Q, Damschroder M, Feng H, Eck S, Buss N, de Haan L, Pierce AJ, Park H, Sylwester A, Axthelm MK, Picker L, Morris NP, Weinberg A, Hammond SA. Oberst MD, et al. Among authors: auge c. Mol Cancer Ther. 2018 May;17(5):1024-1038. doi: 10.1158/1535-7163.MCT-17-0200. Epub 2018 Mar 15. Mol Cancer Ther. 2018. PMID: 29545330 Free PMC article.

2

Ergot alkaloid glycosides with immunomodulatory activities.

Kren V, Fiserová A, Augé C, Sedmera P, Havlícek V, Síma P. Kren V, et al. Among authors: auge c. Bioorg Med Chem. 1996 Jun;4(6):869-76. doi: 10.1016/0968-0896(96)00074-0. Bioorg Med Chem. 1996. PMID: 8818236

3

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.

BenMohamed L, Krishnan R, Auge C, Primus JF, Diamond DJ. BenMohamed L, et al. Among authors: auge c. Immunology. 2002 May;106(1):113-21. doi: 10.1046/j.1365-2567.2002.01396.x. Immunology. 2002. PMID: 11972639 Free PMC article.

4

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ. Villacres MC, et al. Among authors: auge c. J Infect Dis. 2001 Aug 1;184(3):256-67. doi: 10.1086/322028. Epub 2001 Jul 10. J Infect Dis. 2001. PMID: 11443550

5

Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion.

Villacres MC, Longmate J, Auge C, Diamond DJ. Villacres MC, et al. Among authors: auge c. Hum Immunol. 2004 May;65(5):476-85. doi: 10.1016/j.humimm.2004.02.021. Hum Immunol. 2004. PMID: 15172447

6

Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.

BenMohamed L, Krishnan R, Longmate J, Auge C, Low L, Primus J, Diamond DJ. BenMohamed L, et al. Among authors: auge c. Hum Immunol. 2000 Aug;61(8):764-79. doi: 10.1016/s0198-8859(00)00139-7. Hum Immunol. 2000. PMID: 10980387

7

Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity.

Villacres MC, Lacey SF, Auge C, Longmate J, Leedom JM, Diamond DJ. Villacres MC, et al. Among authors: auge c. J Infect Dis. 2003 Sep 15;188(6):908-18. doi: 10.1086/377582. Epub 2003 Sep 9. J Infect Dis. 2003. PMID: 12964124

8

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.

Muller WJ, Madhi SA, Seoane Nuñez B, Baca Cots M, Bosheva M, Dagan R, Hammitt LL, Llapur CJ, Novoa JM, Saez Llorens X, Grenham A, Kelly EJ, Mankad VS, Shroff M, Takas T, Leach A, Villafana T; MELODY Study Group. Muller WJ, et al. N Engl J Med. 2023 Apr 20;388(16):1533-1534. doi: 10.1056/NEJMc2214773. Epub 2023 Apr 5. N Engl J Med. 2023. PMID: 37018470 No abstract available.

9

Development and Validation of a Gas Chromatography-Mass Spectrometry Method for Determining Acaricides in Bee Pollen.

Fuente-Ballesteros A, Augé C, Bernal J, Ares AM. Fuente-Ballesteros A, et al. Among authors: auge c. Molecules. 2023 Mar 9;28(6):2497. doi: 10.3390/molecules28062497. Molecules. 2023. PMID: 36985469 Free PMC article.

10

Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation.

Augé C, Dizeyi N, Ramnemark L, Lluel P, Grabe M. Augé C, et al. Scand J Urol. 2022 Aug;56(4):320-328. doi: 10.1080/21681805.2022.2090602. Epub 2022 Jun 29. Scand J Urol. 2022. PMID: 35766197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page